the new EMA Q&A document dated 8 April 2025 (“Guidance on Good Manufacturing Practice and Good Distribution Practice: Questions and Answers”) makes direct reference to our business model and outlines specific expectations regarding the assessment of potential conflicts of interest in third-party audits.We explicitly welcome this development – because the independence of our auditors has...
The pharmaceutical industry in India is growing rapidly and is also becoming increasingly important as a supplier for us in Europe. Heacon Service GmbH has responded to this and established a location in India to provide your suppliers with optimum local support. In April 2024, Heacon Pharma Audit & Consultancy Pvt Ltd. officially started operations in India. We are now available in Bhopal,...
In spring 2024, the new VDI expert recommendation "3rd Party GMP Audits - Supplier Audits in the Pharmaceutical Industry" was published. The document provides a structured and professional method for evaluating and improving 3rd party audit processes. The expert recommendation method helps to increase the quality, efficiency and compliance of a company. The benefits of 3rd party audits outweigh...
